Drug therapy versus placebo or usual care for comatose survivors of cardiac arrest; a systematic review with meta-analysis
(2024) In Resuscitation 205.- Abstract
Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes. Methods: We searched Medline, EMBASE, the Cochrane Central Register of Controlled Trials, and The International Clinical Trials Registry Platform for randomized controlled trials of drug therapy in comatose survivors of cardiac arrest (last searched 20th October 2024). The primary outcome was mortality at 30 days/hospital discharge. Other outcomes reflected those of the Core Outcome Set for Cardiac Arrest. Risk of bias was assessed using Cochrane... (More)
Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes. Methods: We searched Medline, EMBASE, the Cochrane Central Register of Controlled Trials, and The International Clinical Trials Registry Platform for randomized controlled trials of drug therapy in comatose survivors of cardiac arrest (last searched 20th October 2024). The primary outcome was mortality at 30 days/hospital discharge. Other outcomes reflected those of the Core Outcome Set for Cardiac Arrest. Risk of bias was assessed using Cochrane Risk-Of-Bias Version 1. Studies of steroids, coenzyme Q10 and thiamine were meta-analysed. Results: From 2562 records, 207 full texts were screened and 45 studies (5800 patients) investigating 30 therapies were included. Studies were grouped thematically as supportive drug therapies (n = 10), neuroprotective agents (n = 19), and anti-inflammatory/antioxidants (n = 16). Four studies reported reduced mortality at 30 days/hospital discharge: one of the anticholinergic penehyclidine hydrochloride, two of intra-arrest vasopressin and methylprednisolone plus hydrocortisone for post resuscitation shock, and one of the traditional Chinese medicine, shenfu. Studies of steroids, coenzyme Q10 and thiamine were meta-analysed. We could not detect an effect on mortality with steroids (n = 739, risk ratio (RR), 0.93; 95 % CI 0.83–1.04, p = 0.21; I2 = 60 %, low certainty), coenzyme Q10 (n = 107, RR, 0.91; 95 % CI 0.61–1.37, p = 0.65; I2 = 0 %, low certainty), or thiamine (n = 149, RR, 1.11; 95 % CI 0.88–1.40, p = 0.39; I2 = 0 %, very low certainty). Conclusion: In comatose survivors of cardiac arrest, the majority of trials of drug therapy reported no effect on mortality. Meta-analyses of steroids, coenzyme Q10 and thiamine demonstrated no evidence of an effect on mortality. However, the low certainty of evidence warrants further research.
(Less)
- author
- organization
- publishing date
- 2024-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Anti-inflammatory, Antioxidant, Chain of survival, In-hospital cardiac arrest, Neuroprotection, Out-of-hospital cardiac arrest
- in
- Resuscitation
- volume
- 205
- article number
- 110431
- publisher
- Elsevier
- external identifiers
-
- pmid:39547562
- scopus:85209255233
- ISSN
- 0300-9572
- DOI
- 10.1016/j.resuscitation.2024.110431
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2024 The Author(s)
- id
- ebf5d038-593f-41ff-9c86-d91360ba1209
- date added to LUP
- 2025-01-10 14:31:38
- date last changed
- 2025-07-12 05:50:43
@article{ebf5d038-593f-41ff-9c86-d91360ba1209,
abstract = {{<p>Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes. Methods: We searched Medline, EMBASE, the Cochrane Central Register of Controlled Trials, and The International Clinical Trials Registry Platform for randomized controlled trials of drug therapy in comatose survivors of cardiac arrest (last searched 20th October 2024). The primary outcome was mortality at 30 days/hospital discharge. Other outcomes reflected those of the Core Outcome Set for Cardiac Arrest. Risk of bias was assessed using Cochrane Risk-Of-Bias Version 1. Studies of steroids, coenzyme Q10 and thiamine were meta-analysed. Results: From 2562 records, 207 full texts were screened and 45 studies (5800 patients) investigating 30 therapies were included. Studies were grouped thematically as supportive drug therapies (n = 10), neuroprotective agents (n = 19), and anti-inflammatory/antioxidants (n = 16). Four studies reported reduced mortality at 30 days/hospital discharge: one of the anticholinergic penehyclidine hydrochloride, two of intra-arrest vasopressin and methylprednisolone plus hydrocortisone for post resuscitation shock, and one of the traditional Chinese medicine, shenfu. Studies of steroids, coenzyme Q10 and thiamine were meta-analysed. We could not detect an effect on mortality with steroids (n = 739, risk ratio (RR), 0.93; 95 % CI 0.83–1.04, p = 0.21; I<sup>2</sup> = 60 %, low certainty), coenzyme Q10 (n = 107, RR, 0.91; 95 % CI 0.61–1.37, p = 0.65; I<sup>2</sup> = 0 %, low certainty), or thiamine (n = 149, RR, 1.11; 95 % CI 0.88–1.40, p = 0.39; I<sup>2</sup> = 0 %, very low certainty). Conclusion: In comatose survivors of cardiac arrest, the majority of trials of drug therapy reported no effect on mortality. Meta-analyses of steroids, coenzyme Q10 and thiamine demonstrated no evidence of an effect on mortality. However, the low certainty of evidence warrants further research.</p>}},
author = {{McGuigan, Peter J. and Pauley, Ellen and Eastwood, Glenn and Hays, Leanne M.C. and Jakobsen, Janus C. and Moseby-Knappe, Marion and Nichol, Alistair D. and Nielsen, Niklas and Skrifvars, Markus B. and Blackwood, Bronagh and McAuley, Daniel F.}},
issn = {{0300-9572}},
keywords = {{Anti-inflammatory; Antioxidant; Chain of survival; In-hospital cardiac arrest; Neuroprotection; Out-of-hospital cardiac arrest}},
language = {{eng}},
publisher = {{Elsevier}},
series = {{Resuscitation}},
title = {{Drug therapy versus placebo or usual care for comatose survivors of cardiac arrest; a systematic review with meta-analysis}},
url = {{http://dx.doi.org/10.1016/j.resuscitation.2024.110431}},
doi = {{10.1016/j.resuscitation.2024.110431}},
volume = {{205}},
year = {{2024}},
}